|
2024
|
G/S
|
Chemical preparations for scientific and industrial purposes; genetically engineered polypeptides... |
|
|
G/S
|
Chemical preparations for scientific and industrial
purposes; genetically engineered polypeptide... |
|
|
Invention
|
Heterocyclic kinase inhibitors and uses thereof.
The invention relates to kinase inhibitors, in ... |
|
|
G/S
|
Chemical preparations for scientific and industrial purposes; Polypeptides and proteins produced ... |
|
|
Invention
|
Platform technology for the identification of modulators of immune effector cell function. [1] Th... |
|
|
Invention
|
Combinations of halogenated heterocyclic kinase inhibitors and vegfr inhibitors. The present inve... |
|
2023
|
Invention
|
Cross-specific antigen binding proteins (abp) targeting leukocyte immunoglobulin-like receptor su... |
|
|
Invention
|
Combination therapies based on pd-1 inhibitors and sik3 inhibitors.
The invention relates to a u... |
|
|
Invention
|
Combination therapies based on pd-1 inhibitors and sik3 inhibitors. The invention relates to a us... |
|
|
Invention
|
Sik3 inhibitors for treating diseases resistant to death receptor signalling.
The invention is b... |
|
|
Invention
|
Sik3 inhibitors for treating diseases resistant to death receptor signalling. [1] The invention i... |
|
2022
|
Invention
|
A synthesis scheme and procedures for preparing a sik3 inhibitor and intermediates thereof. The p... |
|
|
G/S
|
Chemical preparations for scientific purposes, other than
for medical or veterinary use; chemica... |
|
|
G/S
|
Chemical preparations for scientific purposes, other than for medical or veterinary use; chemical... |
|
2021
|
G/S
|
Chemical substances, chemical materials and chemical preparations, and natural elements; Chemical... |
|
|
Invention
|
Antibodies binding igc2 of igsf11 (vsig3) and uses thereof. The invention is based on the surpris... |
|
|
Invention
|
Intracellular kinase associated with resistance against t-cell mediated cytotoxicity, and uses th... |
|
|
Invention
|
Bicyclic kinase inhibitors and uses thereof.
The invention relates to kinase inhibitors, in part... |
|
|
Invention
|
Bicyclic kinase inhibitors and uses thereof. The invention relates to kinase inhibitors, in parti... |
|
|
Invention
|
Halogenated-heteroaryl and other heterocyclic kinase inhibitors, and uses thereof.
The invention... |
|
|
Invention
|
Halogenated-heteroaryl and other heterocyclic kinase inhibitors, and uses thereof. inter-aliainte... |
|
|
Invention
|
Halogenated-heteroaryl and other heterocyclic kinase inhibitors, and uses thereof. The invention ... |
|
2020
|
Invention
|
Antibodies binding igv of igsf11 (vsig3) and uses thereof.
The invention is based on the surpris... |
|
|
Invention
|
Antibodies binding igc2 of igsf11 (vsig3) and uses thereof.
The invention is based on the surpri... |
|
|
Invention
|
Antibodies binding igv of igsf11 (vsig3) and uses thereof. The invention is based on the surprisi... |
|
2019
|
Invention
|
Heterocyclic kinase inhibitors and uses thereof. The invention relates to kinase inhibitors, in p... |
|
|
Invention
|
Dasatinib and another 5-thiazolecarboxamide kinase inhibitor, and uses thereof.
The invention re... |
|
|
Invention
|
Dasatinib and another 5-thiazolecarboxamide kinase inhibitor, and uses thereof. The invention rel... |
|
|
Invention
|
5-thiazolecarboxamide kinase inhibitor and uses thereof. The invention relates to a kinase inhibi... |
|
|
Invention
|
A 5-thiazolecarboxamide kinase inhibitor and uses thereof. The invention relates to a kinase inhi... |
|
|
Invention
|
Antibodies targeting, and other modulators of, an immunoglobulin gene associated with resistance ... |
|
2018
|
Invention
|
Intracellular kinase associated with resistance against anti-tumour immune responses, and uses th... |
|
|
G/S
|
Pharmaceuticals, medical and veterinary preparations, pharmaceutical preparations and formulation... |
|
2017
|
Invention
|
Or10h1 antigen binding proteins and uses thereof.
The invention provides antigen binding protein... |
|
|
Invention
|
Or10h1 antigen binding proteins and uses thereof. The invention provides antigen binding proteins... |
|
|
G/S
|
Pharmaceuticals, medical and veterinary preparations; Pharmaceutical preparations and formulation... |
|
2016
|
G/S
|
Research and development of pharmaceutical and therapeutic preparations in the field of oncology ... |
|
|
G/S
|
Pharmaceutical preparations and therapeutic preparations in the nature of medications and therape... |
